Mutations in HID1 Cause Syndromic Infantile Encephalopathy and Hypopituitarism.


Journal

Annals of neurology
ISSN: 1531-8249
Titre abrégé: Ann Neurol
Pays: United States
ID NLM: 7707449

Informations de publication

Date de publication:
07 2021
Historique:
revised: 15 05 2021
received: 20 07 2020
accepted: 15 05 2021
pubmed: 18 5 2021
medline: 15 9 2021
entrez: 17 5 2021
Statut: ppublish

Résumé

Precursors of peptide hormones undergo posttranslational modifications within the trans-Golgi network (TGN). Dysfunction of proteins involved at different steps of this process cause several complex syndromes affecting the central nervous system (CNS). We aimed to clarify the genetic cause in a group of patients characterized by hypopituitarism in combination with brain atrophy, thin corpus callosum, severe developmental delay, visual impairment, and epilepsy. Whole exome sequencing was performed in seven individuals of six unrelated families with these features. Postmortem histopathological and HID1 expression analysis of brain tissue and pituitary gland were conducted in one patient. Functional consequences of the homozygous HID1 variant p.R433W were investigated by Seahorse XF Assay in fibroblasts of two patients. Bi-allelic variants in the gene HID1 domain-containing protein 1 (HID1) were identified in all patients. Postmortem examination confirmed cerebral atrophy with enlarged lateral ventricles. Markedly reduced expression of pituitary hormones was found in pituitary gland tissue. Colocalization of HID1 protein with the TGN was not altered in fibroblasts of patients compared to controls, while the extracellular acidification rate upon stimulation with potassium chloride was significantly reduced in patient fibroblasts compared to controls. Our findings indicate that mutations in HID1 cause an early infantile encephalopathy with hypopituitarism as the leading presentation, and expand the list of syndromic CNS diseases caused by interference of TGN function. ANN NEUROL 2021;90:149-164.

Identifiants

pubmed: 33999436
doi: 10.1002/ana.26127
pmc: PMC8351430
mid: NIHMS1721542
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

143-158

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM124035
Pays : United States

Informations de copyright

© 2021 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

Références

Hum Genet. 2017 Aug;136(8):921-939
pubmed: 28600779
Mol Biol Cell. 2017 Dec 15;28(26):3870-3880
pubmed: 29074564
Nature. 2011 Oct 26;478(7370):483-9
pubmed: 22031440
Nucleic Acids Res. 2003 Jul 1;31(13):3812-4
pubmed: 12824425
Hum Genet. 2011 Jan;129(1):45-50
pubmed: 20967465
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Bioinformatics. 2015 Aug 15;31(16):2745-7
pubmed: 25851949
Biochem J. 2011 Mar 15;434(3):383-90
pubmed: 21250940
Protein Cell. 2011 Jan;2(1):74-85
pubmed: 21337012
Hum Mutat. 2011 Feb;32(2):231-9
pubmed: 21280149
Genetics. 2003 Sep;165(1):127-44
pubmed: 14504222
Nat Methods. 2014 Apr;11(4):361-2
pubmed: 24681721
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Curr Protoc Bioinformatics. 2013;43:11.10.1-11.10.33
pubmed: 25431634
Hum Mutat. 2013 May;34(5):686-96
pubmed: 23420520
Ann Med. 2012 Sep;44(6):542-54
pubmed: 21585247
Genome Biol. 2016 Jun 06;17(1):122
pubmed: 27268795
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Hum Mol Genet. 2003 Feb 1;12(3):357-64
pubmed: 12554689
Genetics. 2011 Feb;187(2):467-83
pubmed: 21115972
Hum Mol Genet. 2009 Feb 1;18(3):440-53
pubmed: 18996921
Hum Mol Genet. 2015 May 15;24(10):2771-83
pubmed: 25652408
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Int J Mol Sci. 2011;12(9):5461-70
pubmed: 22016602
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
J Biol Chem. 2000 Dec 1;275(48):37765-73
pubmed: 10978325
Nat Rev Mol Cell Biol. 2008 Apr;9(4):273-84
pubmed: 18354421
Nature. 2014 Apr 10;508(7495):199-206
pubmed: 24695229
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Nat Genet. 2008 Jun;40(6):782-8
pubmed: 18469812
J Med Genet. 2012 Jul;49(7):455-61
pubmed: 22652534
Am J Hum Genet. 2002 Oct;71(4):947-51
pubmed: 12161821
Am J Hum Genet. 2016 Oct 6;99(4):894-902
pubmed: 27616477
Genome Res. 2012 Mar;22(3):568-76
pubmed: 22300766
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
J Hepatol. 2016 Aug;65(2):377-85
pubmed: 27151179
Am J Hum Genet. 2003 Feb;72(2):419-28
pubmed: 12491225
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147

Auteurs

Anne Schänzer (A)

Institute of Neuropathology, Justus-Liebig-University, Giessen, Germany.

Melanie T Achleitner (MT)

University Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria.

Dietrich Trümbach (D)

Institute of Developmental Genetics, Helmholtz Center, Munich, Germany.
Institute of Metabolism and Cell Death, Helmholtz Center, Munich, Germany.

Laurence Hubert (L)

Inserm UMR1163, Imagine Institute, Tanslational Genetics, Université de Paris, Paris, France.

Arnold Munnich (A)

Inserm UMR1163, Imagine Institute, Tanslational Genetics, Université de Paris, Paris, France.

Barbara Ahlemeyer (B)

Institute for Anatomy and Cell Biology, Division of Medical Cell Biology, Justus Liebig University, Giessen, Germany.

Maha M AlAbdulrahim (MM)

King Abdullah Bin Abdulaziz University Hospital, Riyadh, Saudi Arabia.

Philipp A Greif (PA)

Experimental Leukemia and Lymphoma Research Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.

Sebastian Vosberg (S)

Experimental Leukemia and Lymphoma Research Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
German Cancer Research Centre (DKFZ), Heidelberg, Germany.

Blake Hummer (B)

Molecular and Cellular Biophysics Program, Department of Biological Sciences, University of Denver, Denver, CO, USA.

René G Feichtinger (RG)

University Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria.

Johannes A Mayr (JA)

University Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria.

Saskia B Wortmann (SB)

University Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria.
Radboud Center for Mitochondrial Medicine, Department of Pediatrics, Amalia Children's Hospital, Radboudumc, Nijmegen, The Netherlands.

Heidi Aichner (H)

Department of Pediatrics, Academic Teaching Hospital, Landeskrankenhaus Feldkirch, Feldkirch, Austria.

Sabine Rudnik-Schöneborn (S)

Division of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.

Anna Ruiz (A)

Genetics Laboratory, UDIAT-Centre Diagnòstic, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Spain.

Elisabeth Gabau (E)

Paediatric Unit, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Spain.

Jacobo Pérez Sánchez (JP)

Paediatric Unit, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Spain.

Sian Ellard (S)

Genomic Laboratory, Royal Devon & Exeter NHS Foundation Trust, Exeter, UK.
College of Medicine and Health, University of Exeter, Exeter, UK.

Tessa Homfray (T)

Saint George's University Hospital and Royal Brompton Hospital, London, UK.

Karen L Stals (KL)

Genomic Laboratory, Royal Devon & Exeter NHS Foundation Trust, Exeter, UK.

Wolfgang Wurst (W)

Institute of Developmental Genetics, Helmholtz Center, Munich, Germany.
Chair of Developmental Genetics, Faculty of Life and Food Sciences Weihenstephan, Technische Universität München, Freising-Weihenstephan, Germany.
Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. (DZNE), Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Ludwig-Maximilians-Universität, Munich, Germany.

Bernd A Neubauer (BA)

Department of Child Neurology, Justus-Liebig-University, Giessen, Germany.

Till Acker (T)

Institute of Neuropathology, Justus-Liebig-University, Giessen, Germany.

Stefan K Bohlander (SK)

Leukaemia and Blood Cancer Research Unit, Department of Molecular Medicine and Pathology, The University of Auckland, Auckland, New Zealand.

Cédric Asensio (C)

Molecular and Cellular Biophysics Program, Department of Biological Sciences, University of Denver, Denver, CO, USA.

Claude Besmond (C)

Inserm UMR1163, Imagine Institute, Tanslational Genetics, Université de Paris, Paris, France.

Fowzan S Alkuraya (FS)

Department of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Moenaldeen D AlSayed (MD)

Department of Medical Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Andreas Hahn (A)

Department of Child Neurology, Justus-Liebig-University, Giessen, Germany.

Axel Weber (A)

Institute of Human Genetics, Justus-Liebig-University, Giessen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH